Streetbeat News

Revenues

NCLH

During a conference call, an executive from Norwegian Cruise Line Holdings reported continued healthy demand across all markets, brands, and products, including Europe and Alaska.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 2:17 pm

NCLH

During a conference call, an executive from Norwegian Cruise Line Holdings reported that demand for cruise vacations remains at an all-time high, with the company experiencing record booking positions and record advanced ticket sales.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 2:09 pm

LLY

In the past three months, 23 analysts have provided ratings for Eli Lilly and Co (NYSE:LLY), showing a predominantly bullish outlook with an increase in the average 12-month price target to $833.91 from $728.79. The ratings reflect a mix of 'Buy', 'Overweight', and 'Neutral' stances, with significant price target adjustments by analysts from major firms. Eli Lilly's financial indicators such as revenue growth, net margin, and ROA are strong, although its ROE is below industry averages. The company's focus areas include neuroscience, cardiometabolic, cancer, and immunology.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 2:01 pm

MPLX

MPLX (NYSE:MPLX) received varied analyst ratings in the last quarter, with 4 analysts offering views ranging from bullish to bearish. Recent updates show an increase in the average 12-month price target to $46.25, up 5.71% from the previous $43.75. Analysts from Stifel, UBS, and Barclays have raised their price targets, reflecting a positive outlook on MPLX's financial performance, including revenue growth, net margin, and ROE, which surpass industry averages. MPLX's strong market position is supported by its pipeline and processing assets, with significant operations in the Appalachian region.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 2:01 pm

EPD

Enterprise Prods Partners (NYSE:EPD) has been evaluated by 11 analysts over the last three months, showing a mix of bullish and somewhat bullish sentiments. The average 12-month price target for EPD has increased by 4.41% to $33.64, with a high estimate of $36.00 and a low of $31.00. Analyst actions include ratings adjustments and price target changes, reflecting a positive outlook on the company's performance and market position. Enterprise Products Partners, a major midstream company, has shown impressive revenue growth and effective asset utilization, though it faces challenges in profitability and return on equity.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 2:00 pm

SYK

Analyst ratings for Stryker (NYSE:SYK) show a mix of bullish to bearish sentiments, with recent updates indicating a positive trend. The average 12-month price target for SYK has been raised to $380.44, reflecting a 5.5% increase from the previous target. Analysts from firms like Piper Sandler, Stifel, and Citigroup have raised their price targets, citing the company's strong financial health, market leadership in medical equipment, and positive revenue growth. Stryker's market capitalization and financial metrics such as net margin, ROE, and ROA surpass industry averages, indicating robust financial performance and investor confidence.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 2:00 pm

APP

Recent analysis of AppLovin (NASDAQ:APP) by 9 analysts shows a mix of bullish to bearish sentiments, with an updated average 12-month price target of $76.56, marking a 26.15% increase from the previous target. Analysts from firms like Stifel, Morgan Stanley, and Goldman Sachs have raised their price targets, reflecting optimism about the company's performance. AppLovin's financial indicators such as revenue growth, net margin, ROE, and ROA outperform industry averages, although its debt management poses a challenge.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 2:00 pm

ITW

Analyst ratings for Illinois Tool Works (NYSE:ITW) show a mix of bullish to bearish sentiments, with recent updates indicating a positive shift in price targets. The average 12-month price target has risen to $261.43, reflecting a 2.19% increase. Analyst actions include both upgrades and downgrades, with price targets ranging from $224 to $305. Illinois Tool Works, a diversified global manufacturer, has shown notable financial performance with strong net margin, ROE, and ROA, despite a high debt-to-equity ratio and lower revenue growth compared to peers.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 2:00 pm

DD

DuPont De Nemours, Inc. (DD) reported a mixed first-quarter fiscal 2024 with a 3% year-over-year sales decline to $2.931 billion, surpassing consensus estimates. Organic sales dropped by 6%, with varying declines across regions. The company saw a notable recovery in the electronics market, with significant volume growth in Semiconductor Technologies and Interconnect Solutions. Despite a decrease in Water & Protection sales and a contraction in operating EBITDA margins, DuPont beat adjusted EPS expectations and reported a substantial increase in adjusted free cash flow. The company anticipates sequential sales and earnings improvement in Q2 2024, driven by favorable seasonality and continued recovery in electronics. DuPont has raised its 2024 outlook for adjusted EPS and revenue, reflecting optimism about its future performance. Shares surged 7.77% to $78.13 following the announcement.

Portfolio Pulse from Akanksha Bakshi

May 01, 2024 | 1:43 pm

BNTX

GSK

PFE

GSK Plc reported a 10% year-over-year increase in first-quarter sales, reaching $9.33 billion, driven by strong demand for vaccines and asthma drugs. Vaccine sales rose 16%, with Shingrix and Arexvy showing significant growth. Specialty Medicine sales, including HIV, respiratory/immunology, and oncology, increased by 17%. GSK raised its 2024 outlook, expecting adjusted EPS growth of 8% to 10% and sales growth at the upper end of its 5% to 7% forecast. The company also filed a lawsuit against Pfizer Inc. and BioNTech SE for patent infringement related to mRNA COVID-19 vaccines.

Portfolio Pulse from Vandana Singh

May 01, 2024 | 1:42 pm